These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9504685)

  • 1. Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia.
    Tavassoli FA
    Mod Pathol; 1998 Feb; 11(2):140-54. PubMed ID: 9504685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
    Renshaw AA; Derhagopian RP; Martinez P; Gould EW
    Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies.
    Renshaw AA; Cartagena N; Schenkman RH; Derhagopian RP; Gould EW
    Am J Clin Pathol; 2001 Jul; 116(1):92-6. PubMed ID: 11447758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S; Loya A; Khalbuss W
    Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ).
    Gupta SK; Douglas-Jones AG; Fenn N; Morgan JM; Mansel RE
    Cancer; 1997 Nov; 80(9):1740-5. PubMed ID: 9351542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type--benign and malignant intraductal proliferations.
    Moinfar F; Man YG; Lininger RA; Bodian C; Tavassoli FA
    Am J Surg Pathol; 1999 Sep; 23(9):1048-58. PubMed ID: 10478664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
    Dauplat MM; Penault-Llorca F
    Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear cytometric changes in breast carcinogenesis.
    Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
    J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinoma in situ of the breast].
    Laenkholm AV; Hoffmann J; Rank FE
    Ugeskr Laeger; 2007 Sep; 169(37):3087-90. PubMed ID: 17877955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer.
    Mariuzzi L; Mombello A; Rucco V; Morelli L; Zamò A; Thompson D; Vaught L; Bartels HG; Mariuzzi G; Bartels PH
    Adv Clin Path; 2000 Apr; 4(2):87-97. PubMed ID: 11080789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
    Boyages J; Delaney G; Taylor R
    Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative study of breast cancer progression: different pathways for various in situ cancers.
    Mariuzzi L; Mombello A; Granchelli G; Rucco V; Tarocco E; Frank D; Davis J; Thompson D; Bartels H; Mariuzzi GM; Bartels PH
    Mod Pathol; 2002 Jan; 15(1):18-25. PubMed ID: 11796837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computerized scene segmentation for the discrimination of architectural features in ductal proliferative lesions of the breast.
    Anderson NH; Hamilton PW; Bartels PH; Thompson D; Montironi R; Sloan JM
    J Pathol; 1997 Apr; 181(4):374-80. PubMed ID: 9196433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with the Advanced Breast Biopsy Instrumentation (ABBI) system.
    Watermann DO; Einert A; Ehritt-Braun C; Hasenburg A; Kieback DG
    Anticancer Res; 2002; 22(5):3067-70. PubMed ID: 12530044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between type and grade of ductal carcinoma in situ and concomitant invasive ductal carcinoma of the breast.
    Rudnicka L; Stachura J
    Pol J Pathol; 2000; 51(3):137-43. PubMed ID: 11247396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of disease progression in ductal carcinoma in situ of the breast and vascular patterns.
    Adler EH; Sunkara JL; Patchefsky AS; Koss LG; Oktay MH
    Hum Pathol; 2012 Apr; 43(4):550-6. PubMed ID: 21925705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.